These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36913305)

  • 1. C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
    Klempnauer KH
    Oncotarget; 2023 Mar; 14():174-177. PubMed ID: 36913305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Yusenko MV; Trentmann A; Casolari DA; Abdel Ghani L; Lenz M; Horn M; Dörner W; Klempnauer S; Mootz HD; Arteaga MF; Mikesch JH; D'Andrea RJ; Gonda TJ; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Oncogene; 2021 Jul; 40(29):4746-4758. PubMed ID: 33958723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module.
    Klempnauer KH
    Exp Hematol; 2022 Apr; 108():8-15. PubMed ID: 35032593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
    Kintscher J; Yamkamon V; Braas D; Klempnauer KH
    Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells.
    Abdel Ghani L; Yusenko MV; Frank D; Moorthy R; Widen JC; Dörner W; Khandanpour C; Harki DA; Klempnauer KH
    Cancer Lett; 2022 Apr; 530():170-180. PubMed ID: 35077804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.
    Chayka O; Kintscher J; Braas D; Klempnauer KH
    Mol Cell Biol; 2005 Jan; 25(1):499-511. PubMed ID: 15601869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module.
    Schmidt TJ; Klempnauer KH
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1.
    Zhao L; Ye P; Gonda TJ
    Oncogene; 2014 Aug; 33(35):4442-9. PubMed ID: 24121275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
    Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
    Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter.
    Tahirov TH; Sato K; Ichikawa-Iwata E; Sasaki M; Inoue-Bungo T; Shiina M; Kimura K; Takata S; Fujikawa A; Morii H; Kumasaka T; Yamamoto M; Ishii S; Ogata K
    Cell; 2002 Jan; 108(1):57-70. PubMed ID: 11792321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
    Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
    Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression.
    Ye P; Zhao L; Gonda TJ
    Leuk Res; 2013 May; 37(5):595-601. PubMed ID: 23398943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction and functional collaboration of p300 and C/EBPbeta.
    Mink S; Haenig B; Klempnauer KH
    Mol Cell Biol; 1997 Nov; 17(11):6609-17. PubMed ID: 9343424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).
    Steinmann S; Coulibaly A; Ohnheiser J; Jakobs A; Klempnauer KH
    J Biol Chem; 2013 Aug; 288(31):22257-69. PubMed ID: 23782693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.
    Wethkamp N; Klempnauer KH
    J Biol Chem; 2009 Oct; 284(42):28783-94. PubMed ID: 19690170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.
    Takao S; Forbes L; Uni M; Cheng S; Pineda JMB; Tarumoto Y; Cifani P; Minuesa G; Chen C; Kharas MG; Bradley RK; Vakoc CR; Koche RP; Kentsis A
    Elife; 2021 Feb; 10():. PubMed ID: 33527899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ.
    Falkenberg KD; Jakobs A; Matern JC; Dörner W; Uttarkar S; Trentmann A; Steinmann S; Coulibaly A; Schomburg C; Mootz HD; Schmidt TJ; Klempnauer KH
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1349-1358. PubMed ID: 28476645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.